Bruce Caswell Sells 8,000 Shares of Maximus, Inc. (NYSE:MMS) Stock

Maximus, Inc. (NYSE:MMS) President Bruce Caswell sold 8,000 shares of Maximus stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $60.97, for a total transaction of $487,760.00. Following the completion of the sale, the president now owns 35,904 shares of the company’s stock, valued at approximately $2,189,066.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.

Bruce Caswell also recently made the following trade(s):

  • On Wednesday, August 16th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $60.50, for a total transaction of $484,000.00.
  • On Thursday, August 10th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $59.83, for a total transaction of $478,640.00.
  • On Wednesday, July 12th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $62.21, for a total transaction of $497,680.00.
  • On Friday, June 16th, Bruce Caswell sold 8,000 shares of Maximus stock. The shares were sold at an average price of $63.56, for a total transaction of $508,480.00.
  • On Monday, June 5th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $63.48, for a total transaction of $507,840.00.
  • On Tuesday, May 23rd, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $62.76, for a total transaction of $502,080.00.
  • On Thursday, May 18th, Bruce Caswell sold 8,000 shares of Maximus stock. The stock was sold at an average price of $61.79, for a total transaction of $494,320.00.
  • On Thursday, May 11th, Bruce Caswell sold 17,197 shares of Maximus stock. The stock was sold at an average price of $62.47, for a total transaction of $1,074,296.59.

Shares of Maximus, Inc. (NYSE:MMS) opened at 59.30 on Friday. The firm’s 50-day moving average is $60.78 and its 200 day moving average is $61.00. The stock has a market capitalization of $3.85 billion, a P/E ratio of 19.01 and a beta of 1.39. Maximus, Inc. has a 12-month low of $43.69 and a 12-month high of $64.97.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.03. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The firm had revenue of $600.40 million for the quarter, compared to analysts’ expectations of $614.12 million. During the same period in the previous year, the firm earned $0.79 EPS. The business’s quarterly revenue was down 2.7% on a year-over-year basis. On average, equities research analysts forecast that Maximus, Inc. will post $3.12 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th will be given a dividend of $0.045 per share. The ex-dividend date is Friday, August 11th. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.30%. Maximus’s payout ratio is currently 5.73%.

TRADEMARK VIOLATION NOTICE: “Bruce Caswell Sells 8,000 Shares of Maximus, Inc. (NYSE:MMS) Stock” was first reported by BNB Daily and is the sole property of of BNB Daily. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/19/maximus-inc-nysemms-president-sells-487760-00-in-stock-updated-updated.html.

A number of hedge funds and other institutional investors have recently bought and sold shares of MMS. Neuburgh Advisers LLC boosted its position in Maximus by 1.9% in the first quarter. Neuburgh Advisers LLC now owns 1,696 shares of the health services provider’s stock worth $105,000 after buying an additional 32 shares in the last quarter. Acrospire Investment Management LLC boosted its position in Maximus by 183.3% in the first quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock worth $106,000 after buying an additional 1,100 shares in the last quarter. Glen Harbor Capital Management LLC boosted its position in Maximus by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock worth $145,000 after buying an additional 44 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Maximus by 10.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock worth $148,000 after buying an additional 220 shares in the last quarter. Finally, First Bank & Trust boosted its position in Maximus by 4.2% in the second quarter. First Bank & Trust now owns 2,507 shares of the health services provider’s stock worth $157,000 after buying an additional 101 shares in the last quarter. 97.20% of the stock is currently owned by institutional investors.

A number of brokerages have recently issued reports on MMS. KeyCorp restated a “sector weight” rating on shares of Maximus in a research report on Thursday, May 25th. ValuEngine downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Tuesday, May 16th. Canaccord Genuity downgraded shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 price target on the stock. in a research report on Tuesday, July 4th. BidaskClub downgraded shares of Maximus from a “strong-buy” rating to a “buy” rating in a research report on Thursday, July 6th. Finally, Zacks Investment Research upgraded shares of Maximus from a “sell” rating to a “hold” rating in a research report on Wednesday, July 26th. One research analyst has rated the stock with a sell rating and eight have given a hold rating to the company. The company presently has an average rating of “Hold” and an average target price of $62.17.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply